Survey of urological centers and review of the current practice in the evaluation and treatment of prostatic disease in the Kingdom of Saudi Arabia

Saudi Medical Journal

Volumn 17, Issue 6, 1996, Pages 718-725

  Mosli, Hisham A M ^a  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Prostate; Saudi Arabia; Survey

Indexed keywords

EID: 0007511398     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Christensen MM, Bruskewitz RC. Clinical manifestations of benign prostatic hyperplasia and indications for therapeutic intervention. Urol Clinics N Amer 1990; 17: 509-516
2. Barry MJ. Epidemiology and natural history of BPH, AUA: update series. Lesson 2, 1993; 12: 10-15
3. Mebust WK. BPH, Patient care policies/guidelines. AUA: update series, 1993; 12: 226-132.
4. Mosli HA, Farsi HMA, Al Zimaity MF. Evaluation of a symptom score index for measurement of lower urinary symptoms in Arabic form. Saudi Medical Journal 1995, 16 (6): 536-542.
5. Wilkinson AG, Wild SR Survey of urological centers and review of current practice in the preoperative assessment of prostatism Br J Urol 1992;70:43-45.
6. Mosli HA, Farsi HMA, Al Zimaity MF. A proposal for national epidemiological study on BPH. Paper presented at the symposium on benign prostatic hyperplasia: Security Forces Hospital 1994. Riyadh Saudi Arabia.
7. O'Leary MP, Barry MJ, Fowler FJ. Hard measures of subjective outcomes: validating symptom indexes in urology. J Urol 1992; 148: 1546-1548.
8. Barry MJ, Fowler FJ. The methodology for evaluating the subjective outcomes of treatment for benign prostatic hyperplasia, Mosby Year Book Inc. Advances in Urology 1993; 6: 83-99.
9. Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgerwe L, Mebust WK. Cockett and the measurement committee of the American Urological association. The American urological association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549-1557.
10. Barry MJ, Boyle P, Garraway M, et al. Epidemiology and natural history of BPH. The International Consultation on Benign Prostatic Hyperplasia, Paris. June 27-30. 1993. Proceedings, Eds. Cockett ATK, Khoury S, Aso Y, Chatelian C, Denis L, Griffith K, Murphy G. SCI 19-28: 361-507, 553-564.
11. McConnell JD, et al. Clinical practice guidelines. Benign prostatic hyperplasia: diagnosis and treatment. US Department of health and human services, public health service: Agency for health care policy and research (AHCPR). Rockville, Maryland, USA. AHCPR Publication No 94-0582, February 1994.
12. De Lacey G, Johnson S, Mee D. Prostatism. how useful is routine imaging of the urinary tract? Br Med J 1988; 296: 965-967.
13. Anandan N, Shetty S, Ibrahim AIA, Ogunbiyi DA, Patil KP Is intravenous urography mandatory in the management of benign prostatic hyperplasia? Annals of Saudi Med 1992; 12: 525-428.
14. Stamey TA. Diagnosis of prostate cancer: a personal view. J Urol 1992; 147: 830-832.
15. Christmas TJ, Chapple CR, Ricards D, Milroy EJG, Turner-Warwick RT. Contemporary flow meters: an assessment of their accuracy and reliability. Br J Urol 1989; 64: 460-461.
16. Girman CJ, Panser LA, Chute CG, Oesterling JE, Barrett DM, Chen CC, Arrighi HM, Guess HA, Lieber MM. Natural history of prostatism: urinary flow rates in a community based study. J Urol 1993; 150: 887-892.